117 related articles for article (PubMed ID: 27245274)
1. A supported liquid extraction LC-MS/MS method for determination of concentrations of GDC-0425, a small molecule Checkpoint kinase 1 inhibitor, in human plasma.
Ding X; Chen Y; Sahasranaman S; Shi Y; McKnight J; Dean B
Biomed Chromatogr; 2016 Dec; 30(12):1984-1991. PubMed ID: 27245274
[TBL] [Abstract][Full Text] [Related]
2. A supported liquid extraction-LC-MS/MS method for determination of GDC-0980 (Apitolisib), a dual small-molecule inhibitor of class 1A phosphoinositide 3-kinase and mammalian target of rapamycin, in human plasma.
Ding X; Li F; McKnight J; Schmidt C; Strooisma K; Shimizu H; Faber K; Ware JA; Dean B
J Pharm Biomed Anal; 2014 Nov; 100():150-156. PubMed ID: 25165011
[TBL] [Abstract][Full Text] [Related]
3. A solid phase extraction-liquid chromatographic-tandem mass spectrometry method for determination of concentrations of GDC-0941, a small molecule class I phosphatidylinositide 3-kinase inhibitor, to support clinical development.
Ding X; Morrison G; Dean B; Hop CE; Tobler L; Percey S; Meng M; Reuschel S; West DA; Holden S; Ware JA
J Pharm Biomed Anal; 2012 Mar; 61():1-7. PubMed ID: 22169467
[TBL] [Abstract][Full Text] [Related]
4. Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS.
Ding X; Faber K; Shi Y; McKnight J; Dorshorst D; Ware JA; Dean B
J Pharm Biomed Anal; 2016 Jul; 126():117-23. PubMed ID: 27187764
[TBL] [Abstract][Full Text] [Related]
5. Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry.
Ding X; Chou B; Graham RA; Cheeti S; Percey S; Matassa LC; Reuschel SA; Meng M; Liu S; Voelker T; Lum BL; Rudewicz PJ; Hop CE
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):785-90. PubMed ID: 20172765
[TBL] [Abstract][Full Text] [Related]
6. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0879 and its metabolite in dog plasma using solid phase extraction.
Chou B; Adler RS; Meng M; Percey S; Dean B; Hop CE; Shin YG
J Pharm Biomed Anal; 2012 Nov; 70():354-61. PubMed ID: 22717139
[TBL] [Abstract][Full Text] [Related]
7. Determination of GDC-0980 (apitolisib), a small molecule dual phosphatidylinositide 3-kinase/mammalian target of rapamycin inhibitor in dog plasma by LC-MS/MS to support a GLP toxicology study.
Ding X; Salphati L; Kim A; Morinello E; Wong L; Pang J; Percey S; Meng M; Reuschel S; Dean B
Biomed Chromatogr; 2015 Aug; 29(8):1274-9. PubMed ID: 25677784
[TBL] [Abstract][Full Text] [Related]
8. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0152 in human plasma using solid-phase extraction.
Shin YG; Jones SA; Murakami SC; Budha N; Ware J; Wong H; Buonarati MH; Dean B; Hop CE
Biomed Chromatogr; 2013 Jan; 27(1):102-10. PubMed ID: 22623056
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantitation of polymyxin B1, polymyxin B2 and polymyxin B1-1 in human plasma and treated human urine using solid phase extraction and liquid chromatography-tandem mass spectrometry.
Meng M; Wang L; Liu S; Jaber OM; Gao L; Chevrette L; Reuschel S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():23-36. PubMed ID: 26803416
[TBL] [Abstract][Full Text] [Related]
10. A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma.
Liu J; Yuan L; Liu G; Shen JX; Aubry AF; Arnold ME; Ji QC
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():85-91. PubMed ID: 25930207
[TBL] [Abstract][Full Text] [Related]
11. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0834 and its metabolite in human plasma using semi-automated 96-well protein precipitation.
Shin YG; Jones SA; Murakami SC; Liu L; Wong H; Buonarati MH; Hop CE
Biomed Chromatogr; 2012 Nov; 26(11):1444-51. PubMed ID: 22311651
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a sensitive LC MS/MS method for the measurement of the checkpoint kinase 1 inhibitor prexasertib and its application in a cerebral microdialysis study.
Zhong B; Maharaj A; Davis A; Roussel MF; Stewart CF
J Pharm Biomed Anal; 2018 Jul; 156():97-103. PubMed ID: 29698863
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of loxapine, loxapine N-oxide, amoxapine, 8-hydroxyloxapine and 7-hydroxyloxapine in human plasma using LC-MS/MS.
Meng M; Zhao N; Pederson CC; Harrison E; Green C; Gorman SH; Reuschel S
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():87-97. PubMed ID: 28152454
[TBL] [Abstract][Full Text] [Related]
14. Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.
de Bruijn P; Moghaddam-Helmantel IM; de Jonge MJ; Meyer T; Lam MH; Verweij J; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2009 Dec; 50(5):977-82. PubMed ID: 19628352
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography-tandem mass spectrometric assay for the tyrosine kinase inhibitor afatinib in mouse plasma using salting-out liquid-liquid extraction.
Sparidans RW; van Hoppe S; Rood JJ; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():118-23. PubMed ID: 26826475
[TBL] [Abstract][Full Text] [Related]
16. Determination of cobimetinib in human plasma using protein precipitation extraction and high-performance liquid chromatography coupled to mass spectrometry.
Deng Y; Musib L; Choo E; Chapple M; Burke S; Johnson J; Eppler S; Dean B
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Dec; 972():117-23. PubMed ID: 25444546
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of LC-MS/MS method for quantitative determination of (-)-securinine in mouse plasma.
Wabuyele SL; Wald D; Xu Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():19-26. PubMed ID: 24786218
[TBL] [Abstract][Full Text] [Related]
18. Validation of a liquid chromatography-triple quadrupole mass spectrometric method for the determination of 5-nitro-5'-hydroxy-indirubin-3'-oxime (AGM-130) in human plasma and its application to microdose clinical trial.
Park MH; Lee YY; Cho KH; La S; Lee HJ; Yim DS; Ban S; Park MY; Kim YC; Kim YG; Shin YG
Biomed Chromatogr; 2016 Mar; 30(3):323-9. PubMed ID: 26139072
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry employing an automated liquid-liquid extraction based on 96-well format plates. Application to a bioequivalence study.
Apostolou C; Dotsikas Y; Kousoulos C; Loukas YL
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):239-44. PubMed ID: 17113365
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
